Papillary thyroid carcinoma overexpresses fully and underglycosylated mucins together with native and sialylated simple mucin antigens and histo- blood group antigens

Endocrine Pathology

Volumn 10, Issue 4, 1999, Pages 315-324

  Alves, Pedro ^a   Soares, Paula ^a   Fonseca, Elsa ^a,b   Sobrinho Simões, Manuel ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

Histo blood group antigens; Mucins; Papillary thyroid carcinoma; Simple mucin antigens; Thyroid carcinoma

Indexed keywords

BLOOD GROUP ANTIGEN; MONOCLONAL ANTIBODY; MUCIN;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0033509418     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739774     Document Type: Article

References (31)

1. 1. Longenecker BM. Introduction: Glycosylation changes associated to malignancy. Sem Cancer Biol 2:355-356, 1991.
2. 2. Hakomory S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257-331, 1992.
3. 3. Bryne M, Dabelsten E, Nesland JM. The glycosylation pattern in follicular and papillary thyroid carcinomas. Glycosyl Dis 1:119-125, 1995.
4. 4. Fonseca E, Castanhas S, Sobrinho-Simões M. Expression of simple mucin type antigens and Lewis type 1 and type 2 chain antigens in the thyroid gland: an Immunohistochemical study of normal thyroid tissues, benign lesions, and malignant tumors. Endocrine Pathol 7:291-301, 1996.
5. 5. Vierbuchen M, Larena A, Schröder S, Hanisch F, Ortmann M, Larena A, Uhlenbruck G, Fischer R. Blood group antigen expression in medullary carcinoma of the thyroid. An immunohistochemical study on the occurrence of type 1 chain - derived antigens. Virchows Archiv B Cell Pathol 62:79-88, 1992.
6. 6. Vierbuchen M, Schröder S, Larena A, Uhlenbruck G, Fischer R. Native and sialic acid masked Lewis(a) antigen reactivity in medullary thyroid carcinoma. Distinct tumor-associated and prognostic relevant antigens. Virchows Arch 424:205-211, 1994.
7. 7. Yonezawa S, Tachikawa T, Shin S, Sato E. Sialosyl-Tn antigen. Its distribution in normal human tissues and expression in adenocarcinomas. Am J Clin Pathol 98:167-174, 1992.
8. 8. Vierbuchen M, Shröder S, Uhlenbruck G, Ortmann M, Fischer R. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue. Lab Invest 60:726-732, 1989.
9. 9. Fonseca E, Castanhas S, Sobrinho-Simões M. Carbohydrate antigens as oncofetal antigens in papillary carcinoma of the thyroid gland. Endocrine Pathol 8:301-303, 1997.
10. 10. Gendler S.J., Spicer AP. Epithelial Mucin Genes. Annu Rev Physiol 57:607-634, 1995.
11. 11. Girling A, Bartkova J, Burchell J, Gendler S, Gillet C, Taylor-Papadimitriou J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43:1072-1076, 1989.
12. 12. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 53:641-651, 1993.
13. 13. Ho JJL, Kim YS. Do mucins promote tumor cell metastasis? Int Oncology 7:913-926, 1995.
14. 14. Bieche I, Ruffet E, Zweibaum A, Vilde F, Lidereau R, Franc B. MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid. Thyroid 7:725-731, 1997.
15. 15. Gendler SJ, Spicer AP, Lalani EN, Duhig T, Peat N, Burchell J, Pemberto L, Boshell M, Taylor-Papadimitrou J. Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis 144:S42-S47, 1991.
16. 16. Damiani S, Fratamico F, Lapertosa G, Dina R, Eusebi V., Alcian Blue and epithelial membrane antigen are useful markers in differentiating benign from malignat papillae in thyroid lesions. Virchows Archiv A Pathol Anat 419:131-135, 1991.
17. 17. Yamamoto Y, Izumi K, Otsuka H. An immunohistochemical study of epithelial membrane antigen, cytokeratin, and vimentin in papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types. Cancer 70:2326-2333, 1992.
18. 18. Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol 20:964-74, 1996.
19. 19. Hedinger C, Williams E, Sobin L. Histological typing of thyroid tumors. 2nd ed. WHO International histological classification of tumors. Springer-Verlag, Berlin, 1988.
20. 20. LiVolsi V. Surgical pathology of the thyroid. WB Saunders, Philadelphia, 1990.
21. 21. Rosai J. Thyroid gland. In: Ackerman's surgical pathology. 8th ed. Mosby, St. Louis, 1995; pp 493-567.
22. 22. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47:5476-5482, 1987.
23. 23. Reis CA, Sorensen T, Mandel U, David L, Mirgorodskaya K, Roepstorff P, Kihlberg J, Stig-Hansen J-E, Clausen H. Development and characterization of an antibody directed to an α-N-acetyl-D-galactosamine glycosylated MUC2 peptide. Glycoconjugated J 15:51-62, 1998.
24. 24. Reis CA, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roepstorff P, Sobrinho-Simões M. Immunohistochemical study of MUC 5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 74:112-121, 1997.
25. 25. Taylor-Papadimitriou J, Peterson JJ, Arklie J, Burchell J, Ceriani RL, Bodmer WF. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 28:17-21, 1981.
26. 26. Young WW, Johnson HS, Tamura Y, Karlsson KA, Larson G, Parker JMR, Khare DP, Baker DA, Hindsgaul O, Lemieux RU. Characterization of monoclonal antibodies specific for the Lewis A human blood group determinant. J Biol Chem 258:4890-4894, 1983.
27. 27. Magnani JL, Nilsson BL, Brockhaus, Steplewsky Z, Kropowski H, Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentose II. J Biol Chem 257:14365-14369, 1982.
28. 28. Fukushi Y, Hakamori S, Nudelman E, Cochran N. Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that diffetentially recognize mono-, di-, and trifucosylated type 2 chain. J Biol Chem 259:4681-4685.
29. 29. Fonseca E, Sobrinho-Simões M. Expression of Lewis antigens in papillary carcinoma of the thyroid gland (Letter). Virchows Arch 432:483, 1998.
30. 30. Larena A, Vierbuchen M, Schroder S, Larena-Avellaneda A, Hadshiew I, Fischer R. Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens. Langenbecks Arch Chir 318:102-113, 1996.
31. 31. Hanski C, Drechsler K, Hanisch FG, Sheehan J, Manske M, Ogorek D, Klussmann E, Hanski ML, Blank M, Xing PX, et al. Altered glycosation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression. Cancer Res 53:4082-4088, 1993.